Trials / Completed
CompletedNCT00288197
A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
An Open, Prospective, Uncontrolled, Multi-Center Study To Evaluate The Efficacy And Safety Of Voriconazole In Chinese Subjects With Proven Or Probable Serious Invasive Fungal Infections
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 77 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of voriconazole in Chinese patients with proven or probable deep tissue fungal infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | voriconazole |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2006-02-07
- Last updated
- 2008-06-12
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00288197. Inclusion in this directory is not an endorsement.